[Kala-azar. Presentation of 7 cases and review of the literature].
Seven cases of visceral leishmaniasis are reported, whose epidemiologic, clinical, laboratory, evolutive and therapeutical features are presented. Latest findings are described with reference to laboratory tests and new recent possibilities of therapy.
D000965:Antimony / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004338:Drug Combinations / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007223:Infant; D007898:Leishmaniasis, Visceral / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology; D008297:Male; D008536:Meglumine; D000077485:Meglumine Antimoniate; D008795:Metronidazole / Q000627:therapeutic use; D009942:Organometallic Compounds; D013420:Sulfamethoxazole / Q000627:therapeutic use; D014295:Trimethoprim / Q000627:therapeutic use; D015662:Trimethoprim, Sulfamethoxazole Drug Combination
D004338:Drug Combinations; D009942:Organometallic Compounds; D008795:Metronidazole; D008536:Meglumine; D000077485:Meglumine Antimoniate; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D000965:Antimony; D014295:Trimethoprim; D013420:Sulfamethoxazole
Kala-azar. Presentación de siete casos y revisión de la literatura.